Author

B. Linden

h-index 11 View on Semantic Scholar

We have 1 of 42 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Engineered TCR therapy targeting lipid antigens in AML 2306228

CD1d-specific killing was shown that was dependent on CD1d expression, and in cases of high CD1d expression, may be dependent on endogenously self-lipids found in AML cells.

Amandip Bangar, B. Linden, Andrew Kent et al. · Journal of Immunology · 0 citations